课题基金 / 基金详情

Nuclear function of Glycine N-methyltransferase

Nuclear function of Glycine N-methyltransferase
甘氨酸 N-甲基转移酶的核功能
批准号:
7990236
负责人:
Natalia Ivanovna Krupenko
金额:
$22.13万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2012-04-30

项目摘要

项目成果

Natalia Ivanovna Krupenko的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本提案的总体目标是表征甘氨酸N-甲基转移酶(GNMT)的一种新的调节功能,这是一种丰富的代谢酶。GNMT是四个相同亚基的四聚体,催化甲基从s -腺苷蛋氨酸(SAM)转移到甘氨酸,产生肌氨酸(n -甲基甘氨酸)和s -腺苷同型半胱氨酸(SAH)。据信,该反应调节了SAM/SAH比率,而SAM/SAH比率决定了细胞的甲基化电位。5-甲基四氢叶酸可抑制GNMT,这为单碳叶酸池和甲基化循环之间的甲基流动提供了调节机制。因此,酶催化和相关的细胞作用在很大程度上受叶酸和蛋氨酸的可用性控制,而叶酸和蛋氨酸的可用性又取决于膳食供应。重要的是,虽然GNMT在几种人体组织中丰富,但其在肿瘤中表达缺失。我们还表明,到目前为止,在8种癌细胞系中检测不到这种酶。对这一现象的一个可能的解释来自我们最近的实验,该实验证明了酶的功能是细胞增殖的负调节因子。总的来说,以下初步数据,以及我们发表的研究,为目前的应用奠定了基础:(i) GNMT的瞬时表达抑制癌细胞的增殖;(ii)这种效应不能通过补充高叶酸来逆转;(iii) PC3细胞激活ERK通路,作为GNMT表达的促存活机制(但不足以挽救细胞);(iv) gnmt敏感细胞在细胞核中发现该蛋白的存在;(v)耐gnmt的HEK293细胞在细胞核内没有蛋白积累;(v) GNMT赖氨酸残基的体外化学修饰导致四聚体解离成单体,随后单体易位进入细胞核。因此,我们假设GNMT通过调控基因表达来控制细胞增殖。具体来说,我们假设这种作用与SAM转化为SAH的代谢功能无关,而是在转运到细胞核时发挥作用。我们进一步提出核GNMT通过与核蛋白/染色质相互作用影响转录。我们还提出,酶四聚体中GNMT亚基界面上赖氨酸残基的修饰导致解离成单体并使核进入。验证这些假设的具体目的是:(1)表征GNMT的核定位。(2)阐明GNMT向细胞核转运的机制。(3)区分GNMT诱导细胞毒性的细胞质相关代谢和细胞核相关作用。本项目的完成将建立GNMT核调控机制,并明确由该酶控制的细胞过程。
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this proposal is to characterize a novel regulatory function of glycine N- methyltransferase (GNMT), an abundant metabolic enzyme. GNMT exists as a tetramer of four identical subunits and catalyses the transfer of a methyl group from S-adenosylmethionine (SAM) to glycine producing sarcosine (N-methylglycine) and S-adenosylhomocysteine (SAH). It is believed that this reaction regulates the SAM/SAH ratio, which defines the methylation potential of the cell. GNMT is inhibited by 5-methyltetrahydrofolate, which provides a regulatory mechanism for the flow of methyl groups between the one-carbon folate pool and the methylation cycle. As such, enzyme catalysis, and an associated cellular role, is controlled to a significant extent by the availability of folate and methionine, which in turn depends on a dietary supply. Importantly, while GNMT is abundant in several human tissues, its expression is lost in tumors. We have also shown that the enzyme is not detectable in eight cancer cell lines tested so far. A possible explanation of this phenomenon came from our recent experiments, which demonstrated a function of the enzyme as a negative regulator of cellular proliferation. Overall, the following preliminary data, together with our published studies, laid the ground for the present application: (i) transient expression of GNMT suppresses proliferation of cancer cells; (ii) this effect cannot be reversed by high folate supplementation; (iii) PC3 cells activate the ERK pathway as a pro-survival mechanism in response to GNMT expression (but it is not sufficient to rescue cells); (iv) GNMT-sensitive cells revealed the presence of the protein in nuclei; (v) GNMT-resistant HEK293 cells did not accumulate the protein in nuclei; (v) in vitro chemical modification of lysine residues of GNMT causes dissociation of tetramer to monomers, followed by translocation of monomers into the nuclei. Accordingly, we hypothesize that GNMT controls cellular proliferation through regulation of gene expression. Specifically, we hypothesize that this role is not associated with the metabolic function of conversion of SAM to SAH but is exerted upon translocation into nuclei. We further propose that nuclear GNMT affects transcription through interaction with nuclear proteins/chromatin. We also propose that modifications of lysine residues on the interface of GNMT subunits within the enzyme tetramer results in dissociation to monomers and enables the nuclear entry. The specific aims designed to test these hypotheses are: (1) Characterize nuclear localization of GNMT. (2) Elucidate mechanisms promoting translocation of GNMT to the nucleus. (3) Differentiate the cytoplasm-related metabolic and nucleus-associated effects of GNMT in induction of cytotoxicity. Accomplishment of this project will establish a mechanism for GNMT nuclear regulation and define cellular processes controlled by the enzyme. PUBLIC HEALTH RELEVANCE: Folate, an important and essential part of the human diet, regulates many cellular processes including methylation, while folate deficiency promotes many diseases. This application is focused on a novel nucleus-associated function of GNMT, an abundant human enzyme regulated by folate, which lies at an intersection point between folate metabolism and methylation. Since GNMT can function as a restrictor of excessive proliferation in liver and other tissues, understanding its role in cellular metabolism will help to better manage liver related diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ceramide signaling in the regulation of cellular response to folate stress
  • 批准号:
    9250722
  • 项目类别:
  • 资助金额:
    $34.77万
  • 财政年份:
    2015
  • 负责人:
    Natalia Ivanovna Krupenko
  • 依托单位:
CROSS TALK BETWEEN THE SPHINGOLIPID AND FOLATE PATHWAYS
Nuclear function of Glycine N-methyltransferase
CROSS TALK BETWEEN THE SPHINGOLIPID AND FOLATE PATHWAYS
海外基金